Quest Diagnostics Incorporated
DGXQuest Diagnostics Incorporated (DGX) is a Healthcare company that currently yields 1.67% — historically overvalued based on 10 years of dividend yield history. The Weiss valuation model places the undervaluation threshold at $137.37 and the overvaluation threshold at $186.48. Quest Diagnostics Incorporated holds a quality score of 80/100 (Excellent), reflecting 14 consecutive years of dividend growth with a 36% payout ratio. The 5-year dividend CAGR stands at 7.3%.
DGX Dividend Yield History — Weiss Valuation
Distance to undervalued
Entry price is stretched
Needs 29.6% downside to reach the Weiss buy zone
Undervaluation starts near $137.37, where the annual dividend would imply roughly 2.37% yield. That is 0.70% above today's yield.
Buy-zone price
$137.37
Target yield
2.37%
Research checklist
What to clear before buying the yield
Updated May 25, 2026
Dividend durability
14YLong dividend history supports a deeper look.
Earnings payout
36%Earnings coverage leaves room for noise.
Cash payout
40%Free cash flow coverage supports the payment.
Dividend growth
7.3%Recent growth adds income compounding potential.
What changed
What changed since the last update
2026-05-23 → 2026-05-25
No major change in signal, yield, price, quality, or payout since the last update.
Why Now?
Quest Diagnostics Incorporated is trading near its historical overvaluation band.
Current yield 1.7% vs historical max 2.6% (63% of maximum).
14 consecutive years without a dividend cut.
Conservative payout ratio of 36%.
What matters now
Read the signal before the headline yield
Valuation is the brake here: the yield is compressed versus its own history.
The 80/100 quality score keeps DGX on the serious-research list.
Start by checking whether payout coverage and business durability still support the dividend.
DGX Dividend Income Projection — DRIP Compounder
Dividend Compounder (DRIP)
Year 1 Income
$179
Year 10 Income
$419
Yield on Cost
4.33%
Total Income
$2,813
Assumes dividends reinvested at current price. Simplified model — for illustrative purposes only.
More research
Full price history & technical analysis
TradingView ↗Fundamentals, valuation & analyst ratings
FinViz ↗Moat rating & analyst fair value
Morningstar ↗DGX Dividend Quality Score
Quality Score
Excellent
Key Metrics
Invest in DGX
Buy Quest Diagnostics Incorporated commission-free on eToro
Start investing on eToro →DividendVisual may earn a commission if you open an account via this link, at no cost to you. Capital at risk. Not financial advice.
In-depth analysis
→ DGX Dividend Analysis Article